Ramaswamy Vivek

CIK 00016350755 companiesWASHINGTON, DC

SEC Profile

Transactions

Companies

Filings

CIK

0001635075

Recent Transactions

50 trades

Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-15$22.05/sh−478,708→ 33,653,755 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-15$22.05/sh−353,745→ 34,132,463 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-12-15−832,453→ 22,150,227 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-15$12.68/sh+832,453→ 34,486,208 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-12$12.68/sh+4,672,724→ 38,326,479 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-12-12−4,672,724→ 22,982,680 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-12$21.96/sh−1,975,858→ 36,350,621 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-12$21.96/sh−2,696,866→ 33,653,755 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-11$21.64/sh−774,142→ 34,749,305 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-12-11−1,869,691→ 27,655,404 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-11$21.64/sh−1,095,550→ 33,653,755 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-11$12.68/sh+1,869,691→ 35,523,447 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-17$20.51/sh−539,650→ 33,653,756 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-14$20.33/sh−1,027,670→ 34,193,406 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-13$20.81/sh−287,283→ 35,221,076 total
Purchase
Strive, Inc.$ASST
Variable Rate Series A Perpetual Preferred Stock
2025-11-05$80.00/sh+15,625→ 15,625 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-09-05$12.96/sh−385,816→ 35,508,359 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-09-04$12.92/sh−194,933→ 35,894,175 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-09-03$12.50/sh−1,195,000→ 36,089,108 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-20$11.46/sh−577,007→ 37,284,108 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-18$11.45/sh−565,266→ 37,861,115 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-06$11.19/sh−200,800→ 38,426,381 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-04$11.34/sh−547,430→ 38,627,181 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-05-07$11.18/sh−625,000→ 39,174,611 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-05-06$11.47/sh−273,959→ 39,799,611 total
Gift
Roivant Sciences Ltd.$ROIV
Common Shares
2025-01-23−13,357,857→ 40,073,570 total
Gift
Roivant Sciences Ltd.$ROIV
Common Shares
2025-01-23+13,357,857→ 13,357,857 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-01-02$11.05/sh−3,000,000→ 51,929,426 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2023-12-27$11.58/sh−133,911→ 54,929,426 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-12-27+275,227→ 55,063,337 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-12-27$11.50/sh−251,538→ 11,570,769 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-12-27$6.40/sh−611,393→ 7,132,921 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-28$12.67/sh−61,947→ 54,788,110 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-09-27$6.40/sh−203,798→ 7,744,314 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-27+119,534→ 54,850,057 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-09-27$11.50/sh−251,539→ 11,822,307 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-08-28$11.25/sh−47,692→ 54,730,523 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-08-27$6.40/sh−203,798→ 7,948,112 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-08-27+86,714→ 54,778,215 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-07-31$11.43/sh−76,023→ 54,691,501 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-07-27+166,057→ 54,767,524 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-07-27$6.40/sh−407,595→ 8,151,910 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-05-31$9.09/sh−189,947→ 54,601,467 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-05-27+382,203→ 54,791,414 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-05-27$6.40/sh−1,222,787→ 8,559,505 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-02-22$7.95/sh−4,000,000→ 54,409,211 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option (Right to Buy)
2018-06-19+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2017-06-21+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (right to buy)
2016-06-03+7,500→ 7,500 total
Award
Sio Gene Therapies Inc.
Employee Stock Option (Right to Buy)
2016-04-29+357,000→ 357,000 total

Companies

Recent Filings

Address

C/O STEVE ROBERTS 700 PENNSYLVANIA AVE., SE STE. 440

WASHINGTON, DC, 20003

View on SEC.gov